The Cannabis Cancer Connection
Project CBD
OCTOBER 26, 2023
United Kingdom-based GW Pharmaceuticals has produced the world’s first approved cannabis-based medicines for the UK, US, and European markets, Sativex® and Epidiolex®. Epidiolex is a high-CBD tincture, and Sativex® has a roughly 1:1 ratio of THC and CBD. Note: In May 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals.]
Let's personalize your content